Table 1 Clinicopathologic characteristics of enrolled patients
Characteristic | N (%) |
|---|---|
Age, years | |
 < 60 | 26 (65.0) |
 ≥ 60 | 14 (35.0) |
Sex | |
 Female | 14 (35.0) |
 Male | 26 (65.0) |
Pathology | |
 Adenocarcinoma | 37 (92.5) |
 Others | 3 (7.5) |
EGFR status | |
 Wide-type | 21 (52.5) |
 Mutation | 19 (47.5) |
MET exon 14 skipping mutations | |
 Yes | 2 (5.0) |
 No | 38 (95.0) |
MET amplification by FISH | |
 Amplified | 25 (62.5) |
 Non-amplified | 15 (37.5) |
MET amplification by NGS | |
 GCN  ≥ 5 | 10 (25.0) |
 GCN  < 5 | 30 (75.0) |
Focal amplified by NGS | |
 Focal amplified | 16 (40.0) |
 Non-focal amplified | 19 (47.5) |
 Not available | 5 (12.5) |